Merz Pharma Group

17 articles about Merz Pharma Group

• Poseidon rules the waves at LogiPharma 2019

  4/10/2019

  Delegates at the world's largest pharma supply chain event in Montreux learned how the wave-parting Poseidon ocean freight model is opening a clear passage to safety, savings and sustainability.

• Merz Names Terri L. Phillips, M.D., Vice President and Head of Global Medical Affairs

  1/2/2018

  Merz today announced that Terri L. Phillips, M.D., F.A.A.P., has been named Vice President and Head of Global Medical Affairs, effective January 2, 2018.

• Merz Pharma Group Outsources Its Compound Management To BioAscent Discovery

  3/2/2017

• Merz Pharma Group Continues Its Growth In Aesthetics And Neurotoxins

  11/21/2016

• Merz Pharma Group Announces European Approval Of Bocouture For The Treatment Of Upper Facial Lines

  3/17/2016

• Merz Pharma Group North America Announces Internal Promotions within its North American Leadership Team

  9/30/2013

• Merz Pharma Group Acquires Swiss Dermatology Company Neocutis S.A.

  7/31/2013

• Merz Pharma Group Declines to Raise Bid for Obagi Medical Products, Inc., Yielding to Valeant Pharmaceuticals International

  4/8/2013

• Merz Pharma Group Offers $383.5 Million for Obagi Medical Products, Inc., Tops Deal Announced Last Month With Valeant Pharmaceuticals International

  4/2/2013

• Merz Pharma Group Announces Promotion of Hyunna Coelho to Vice President, Commercial Excellence

  10/1/2012

• Merz Pharma Group Announces the Acquisition of CUVPOSA® (glycopyrrolate) Oral Solution, First and Only FDA-Approved Treatment for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions

  8/27/2012

• The Merz Pharma Group Appoints William D. Humphries as New North American Chief Executive Officer

  3/14/2012

• Merz Pharma Group to Complete Acquisition of BioForm Medical, Inc.

  2/19/2010

• Merz Pharma Group Successfully Completes BioForm Medical, Inc. Tender Offer with over 94 Percent of Shares Tendered

  2/16/2010

• Merz Pharma Group Obtains HSR Clearance in Connection with BioForm Medical, Inc. Tender Offer

  2/3/2010

• Merz Pharma Group Commences Tender Offer for All Outstanding Shares of BioForm Medical, Inc.

  1/15/2010

• Merz Pharma Group to Acquire BioForm Medical, Inc. for US $253 Million

  1/5/2010